Free Trial
NASDAQ:INNV

InnovAge (INNV) Stock Price, News & Analysis

InnovAge logo
$4.14 -0.06 (-1.43%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$4.11 -0.03 (-0.72%)
As of 07/11/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About InnovAge Stock (NASDAQ:INNV)

Key Stats

Today's Range
$3.95
$4.16
50-Day Range
$2.89
$4.43
52-Week Range
$2.60
$6.69
Volume
128,742 shs
Average Volume
51,052 shs
Market Capitalization
$558.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Reduce

Company Overview

InnovAge Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

INNV MarketRank™: 

InnovAge scored higher than 20% of companies evaluated by MarketBeat, and ranked 859th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    InnovAge has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    InnovAge has received no research coverage in the past 90 days.

  • Read more about InnovAge's stock forecast and price target.
  • Earnings Growth

    Earnings for InnovAge are expected to grow in the coming year, from ($0.12) to $0.06 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InnovAge is -18.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InnovAge is -18.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    InnovAge has a P/B Ratio of 2.03. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about InnovAge's valuation and earnings.
  • Percentage of Shares Shorted

    1.60% of the float of InnovAge has been sold short.
  • Short Interest Ratio / Days to Cover

    InnovAge has a short interest ratio ("days to cover") of 8.2.
  • Change versus previous month

    Short interest in InnovAge has recently increased by 8.20%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    InnovAge does not currently pay a dividend.

  • Dividend Growth

    InnovAge does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.60% of the float of InnovAge has been sold short.
  • Short Interest Ratio / Days to Cover

    InnovAge has a short interest ratio ("days to cover") of 8.2.
  • Change versus previous month

    Short interest in InnovAge has recently increased by 8.20%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    InnovAge has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for InnovAge this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, InnovAge insiders have bought more of their company's stock than they have sold. Specifically, they have bought $281,922.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 1.40% of the stock of InnovAge is held by insiders.

  • Percentage Held by Institutions

    Only 12.26% of the stock of InnovAge is held by institutions.

  • Read more about InnovAge's insider trading history.
Receive INNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter.

INNV Stock News Headlines

InnovAge (NASDAQ:INNV) Trading 5.1% Higher - What's Next?
Hedge fund legend humiliates Bitcoin traders
Larry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% worldwide. Now he’s applying the same expertise to the Bitcoin market. His system tracks 19 indicators to find quick Bitcoin profit opportunities.
See More Headlines

INNV Stock Analysis - Frequently Asked Questions

InnovAge's stock was trading at $3.93 on January 1st, 2025. Since then, INNV stock has increased by 5.3% and is now trading at $4.14.

InnovAge Holding Corp. (NASDAQ:INNV) released its earnings results on Tuesday, May, 6th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.02) by $0.06. The company earned $218.14 million during the quarter, compared to the consensus estimate of $214.09 million. InnovAge had a negative net margin of 3.75% and a negative trailing twelve-month return on equity of 11.91%.
Read the conference call transcript
.

InnovAge (INNV) raised $301 million in an initial public offering on Thursday, March 4th 2021. The company issued 16,700,000 shares at $17.00-$19.00 per share. J.P. Morgan, Barclays, Goldman Sachs and Citigroup acted as the underwriters for the IPO and Baird, William Blair, Piper Sandler, Capital One Securities, Loop Capital Markets, Siebert Williams Shank and Roberts & Ryan were co-managers.

Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that InnovAge investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), NVIDIA (NVDA), Meta Platforms (META), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Last Earnings
5/06/2025
Today
7/13/2025
Next Earnings (Estimated)
9/09/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:INNV
CIK
1834376
Fax
N/A
Employees
2,350
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$5.00
Potential Upside/Downside
+20.8%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$21.34 million
Net Margins
-3.75%
Pretax Margin
-3.70%
Return on Equity
-11.91%
Return on Assets
-5.85%

Debt

Debt-to-Equity Ratio
0.04
Current Ratio
0.78
Quick Ratio
0.78

Sales & Book Value

Annual Sales
$763.85 million
Price / Sales
0.73
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.04 per share
Price / Book
2.03

Miscellaneous

Outstanding Shares
135,010,000
Free Float
133,123,000
Market Cap
$558.94 million
Optionable
Optionable
Beta
0.51
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:INNV) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners